Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
NICE-aligned management typically involves: Addressing modifiable risk factors (smoking cessation, weight loss, increased physical activity, alcohol reduction) Optimising management of underlying conditions (diabetes, hypertension, depression) Trial of PDE5 inhibitor therapy Referral to specialist services (urology/andrology) if first-line treatments fail or where structural/neurological/endocrine causes are suspected Consideration of psychosexual therapy where appropriate Men should be reassured that ED is a medical condition with effective treatments, and seeking help through proper channels ensures safety, appropriate investigation of underlying causes, and access to evidence-based therapies
Months 6-12 and Beyond: Long-Term Progress Extended use allows for continued slow progress in body composition
GLP-1
ChemBiol Interact
Valuation and Investor Perception As the GLP-1 market transitions from a valuation expansion phase into a more earnings-driven cycle, investor expectations for both firms have recalibrated
US$ 29.06
US$ 28.43
US$ 24.34
